Table 3.
n | Mean | 95% confidence interval | ||
---|---|---|---|---|
Age (y) | NOA | 448 | 35.433 | 34.802–36.064 |
OA | 210 | 35.81 | 34.846–36.773 | |
Cryptozoospermia | 46 | 37.044 | 34.659–39.428 | |
Oligoasthenozoospermia | 1619 | 37.473 | 37.11–37.836 | |
Normal | 1333 | 35.139 | 34.776–35.502 | |
Ejaculation disorder | 6 | 36.5 | 19.543–53.457 | |
LH (miU/mL) | NOA | 446 | 11.923 | 11.274–12.571 |
OA | 210 | 4.758 | 4.407–5.108 | |
Cryptozoospermia | 46 | 6.793 | 5.555–8.032 | |
Oligoasthenozoospermia | 1614 | 5.169 | 5.021–5.317 | |
Normal | 1330 | 4.317 | 4.211–4.422 | |
Ejaculation disorder | 6 | 5.5 | 1.688–9.312 | |
FSH (miU/mL) | NOA | 446 | 26.991 | 25.757–28.226 |
OA | 210 | 5.182 | 4.876–5.488 | |
Cryptozoospermia | 46 | 14.693 | 10.891–18.496 | |
Oligoasthenozoospermia | 1615 | 7.479 | 7.175–7.783 | |
Normal | 1330 | 4.786 | 4.654–4.917 | |
Ejaculation disorder | 6 | 10.85 | -3.149–24.849 | |
PRL (ng/mL) | NOA | 446 | 10.474 | 9.987–10.961 |
OA | 210 | 9.893 | 9.163–10.623 | |
Cryptozoospermia | 46 | 10.135 | 8.428–11.842 | |
Oligoasthenozoospermia | 1614 | 10.271 | 9.762–10.780 | |
Normal | 1330 | 10.997 | 9.262–12.732 | |
Ejaculation disorder | 6 | 12.15 | 6.881–17.419 | |
Testosterone (ng/mL) | NOA | 447 | 4.021 | 3.716–4.325 |
OA | 210 | 4.53 | 4.277–4.783 | |
Cryptozoospermia | 46 | 4.552 | 3.813–5.291 | |
Oligoasthenozoospermia | 1616 | 4.804 | 4.711–4.896 | |
Normal | 1330 | 4.937 | 4.843–5.031 | |
Ejaculation disorder | 6 | 6.902 | -2.815–16.618 | |
E2 (pg/mL) | NOA | 445 | 25.518 | 24.481–26.555 |
OA | 207 | 25.865 | 24.538–27.191 | |
Cryptozoospermia | 46 | 28.615 | 23.575–33.655 | |
Oligoasthenozoospermia | 1611 | 26.391 | 25.774–27.007 | |
Normal | 1330 | 26.033 | 25.546–26.520 | |
Ejaculation disorder | 6 | 35.217 | 5.199–65.235 | |
T (ng/dL)/E2 (pg/mL) | NOA | 444 | 16.6 | 15.651–17.548 |
OA | 207 | 19.288 | 17.913–20.663 | |
Cryptozoospermia | 46 | 17.83 | 14.063–21.597 | |
Oligoasthenozoospermia | 1611 | 20.237 | 19.671–20.805 | |
Normal | 1328 | 20.823 | 20.191–21.454 | |
Ejaculation disorder | 6 | 16.744 | 6.855–26.633 | |
Sperm volume (mL) | NOA | 445 | 2.877 | 2.705–3.048 |
OA | 209 | 2.107 | 1.9–2.325 | |
Cryptozoospermia | 46 | 2.748 | 2.276–3.22 | |
Oligoasthenozoospermia | 1618 | 2.808 | 2.725–2.89 | |
Normal | 1333 | 3.017 | 2.933–3.1 | |
Ejaculation disorder | 4 | 0.075 | -0.005–0.155 | |
Concentration (× 106/mL) | NOA | 448 | 0 | 0–0 |
OA | 210 | 0 | 0–0 | |
Cryptozoospermia | 46 | 0.01 | 0.01–0.01 | |
Oligoasthenozoospermia | 1619 | 29.102 | 26.365–31.839 | |
Normal | 1333 | 79.379 | 44.032–114.727 | |
Ejaculation disorder | 0 | * | * | |
Motility (%) | NOA | 448 | 0 | 0–0 |
OA | 209 | 0 | 0–0 | |
Cryptozoospermia | 46 | 15.063 | 8.096–22.030 | |
Oligoasthenozoospermia | 1619 | 28.549 | 27.676–29.422 | |
Normal | 1333 | 57.533 | 56.95–58.116 | |
Ejaculation disorder | 1 | 2 | * | |
Total sperm motility count (× 106/mL)) | NOA | 448 | 0 | 0–0 |
OA | 210 | 0 | 0–0 | |
Cryptozoospermia | 46 | 0.004 | 0.002–0.006 | |
Oligoasthenozoospermia | 1619 | 17.014 | 15.55–18.479 | |
Normal | 1333 | 94.328 | 87.598–101.059 | |
Ejaculation disorder | 6 | 0 | 0–0 |